These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 8066425)
1. Barriers to drug delivery in solid tumors. Jain RK Sci Am; 1994 Jul; 271(1):58-65. PubMed ID: 8066425 [No Abstract] [Full Text] [Related]
2. Drug delivery and transport to solid tumors. Jang SH; Wientjes MG; Lu D; Au JL Pharm Res; 2003 Sep; 20(9):1337-50. PubMed ID: 14567626 [TBL] [Abstract][Full Text] [Related]
3. Drug penetration in solid tumours. Minchinton AI; Tannock IF Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189 [TBL] [Abstract][Full Text] [Related]
4. Determinants of drug delivery and transport to solid tumors. Au JL; Jang SH; Zheng J; Chen CT; Song S; Hu L; Wientjes MG J Control Release; 2001 Jul; 74(1-3):31-46. PubMed ID: 11489481 [TBL] [Abstract][Full Text] [Related]
5. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. Jain RK J Natl Cancer Inst; 1989 Apr; 81(8):570-6. PubMed ID: 2649688 [No Abstract] [Full Text] [Related]
6. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. Jain RK J Control Release; 2001 Jul; 74(1-3):7-25. PubMed ID: 11489479 [TBL] [Abstract][Full Text] [Related]
7. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Maruyama K Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415 [TBL] [Abstract][Full Text] [Related]
8. Barriers to drug delivery in interventional oncology. Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316 [TBL] [Abstract][Full Text] [Related]
9. Understanding barriers to drug delivery: high resolution in vivo imaging is key. Jain RK Clin Cancer Res; 1999 Jul; 5(7):1605-6. PubMed ID: 10430057 [No Abstract] [Full Text] [Related]
10. Tumour-targeted drug and gene delivery: principles and concepts. Cassidy J; Schätzlein AG Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893 [TBL] [Abstract][Full Text] [Related]
11. Delivery of molecular and cellular medicine to solid tumors. Jain RK J Control Release; 1998 Apr; 53(1-3):49-67. PubMed ID: 9741913 [TBL] [Abstract][Full Text] [Related]
12. Drug targeting and tumor heterogeneity. Bae YH J Control Release; 2009 Jan; 133(1):2-3. PubMed ID: 18848589 [No Abstract] [Full Text] [Related]
13. Multidrug resistance in cancer therapy: role of the microenvironment. Galmarini CM; Galmarini FC Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126 [TBL] [Abstract][Full Text] [Related]
14. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles. Sinek J; Frieboes H; Zheng X; Cristini V Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877 [TBL] [Abstract][Full Text] [Related]
15. Mathematical modelling of liposomal drug release to tumour. Chakravarty K; Dalal DC Math Biosci; 2018 Dec; 306():82-96. PubMed ID: 30391313 [TBL] [Abstract][Full Text] [Related]
16. Transport Barriers and Oncophysics in Cancer Treatment. Nizzero S; Ziemys A; Ferrari M Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312 [TBL] [Abstract][Full Text] [Related]
17. Extravasation of polymeric nanomedicines across tumor vasculature. Danquah MK; Zhang XA; Mahato RI Adv Drug Deliv Rev; 2011 Jul; 63(8):623-39. PubMed ID: 21144874 [TBL] [Abstract][Full Text] [Related]